Results 121 to 130 of about 80,191 (196)

Refining Tolvaptan Dosing in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney360
Dahl NK, Torres VE.
europepmc   +1 more source

Retroperitoneoscopic Nephrectomy at the Time of Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease: Safety, Efficacy, Feasibility, and Cosmetic Outcomes. [PDF]

Transplant Direct
Ohyama T, Nishida S, Minamisono K, Nakao T, Iwami D.   +4 more
europepmc   +1 more source

GLIS3, a novel regulator of eicosanoid gene expression and metabolism in normal kidney and polycystic kidney disease. [PDF]

Biochem Pharmacol
Srivastava C, Kang HS, Edin ML, Mukherjee T, Lih FB, Grimm SA, Collier JB, Zeldin DC, Jetten AM.   +8 more
europepmc   +1 more source

Trajectories of Kidney Function in Autosomal Dominant Polycystic Kidney Disease Patients Treated with Tolvaptan. [PDF]

Medicina (Kaunas)
Jankowska Z, Niemczyk M.
europepmc   +1 more source

Polycystic kidney disease

The Journal-lancet, 2010
openaire   +3 more sources

Congenital Hepatic Fibrosis and/or Autosomal Recessive Polycystic Kidney Disease: A Single-center Experience. [PDF]

Pediatr Gastroenterol Hepatol Nutr
Altay D, Yel S, Dursun İ, Arslan D.
europepmc   +1 more source

A Review of the Management of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Cureus
Raveendran R, Murali V, Fernando H.
europepmc   +1 more source

Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney Disease. [PDF]

J Clin Med
Jankowska M, Qureshi AR, Haarhaus M, Magnusson P, Dębska-Ślizień A, Barany P, Heimburger O, Stenvinkel P, Lindholm B.   +8 more
europepmc   +1 more source

Inferior Vena Cava Thrombosis After Nephrectomy of the Native Kidneys in Patients With Autosomal Dominant Polycystic Kidney Disease. [PDF]

IJU Case Rep
Matsushita Y, Watanabe K, Aoki T, Tsuyuki H, Watanabe H, Tamura K, Katahashi K, Isobe S, Motoyama D, Inamoto T.   +9 more
europepmc   +1 more source